Pierone G, Schulman K, Fusco J, et al. Characteristics of Early Adopters of a Two-Drug Regimen (Dolutegravir/Lamivudine) for Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) in a Real-World Setting. Presented at: ACTHIV 2020; Virtual Meeting.
